This kit is used for qualitative detection of parvovirus B19 IgG antibody in serum or plasma from pregnant women and pregnant women. Human parvovirus B19 is transmitted through the respiratory tract, pregnant women susceptible to up to 23%~45%, if pregnancy women infected with B19, the fetus infection rate is 33% through the placenta, the incidence of stillbirth 6.5%, the incidence of non immune fetal edema 8%~10%. Specific IgM and IgG antibodies are tested to diagnose whether pregnant women are infected with B19 virus. The appearance of IgG antibodies indicates previous infection, IgG antibodies remain positive all their lives and generally obtain lifelong immunity. If pregnant women have a certain level of anti-b19 virus specific IgG, it can protect the fetus, reduce the damage of B19 virus infection. Serological test to detect specific IgG and IgM antibodies is the basis for the diagnosis of B19 infection. Antibody detection methods mainly include radioimmunoassay (RIA) enzyme (ELISA) immunofluorescence assay (IF) and immunoblot assay (WB). This kit assists the detection of parvovirus B19 in pregnant women.
Summary
Sample
Serum or plasma
Species Reactivity
Human
Detection Method
ELISA
Intended Use
This kit is used for qualitative detection of parvovirus B19 IgG antibody in serum or plasma from pregnant women and pregnant women. Human parvovirus B19 is transmitted through the respiratory tract, pregnant women susceptible to up to 23%~45%, if pregnancy women infected with B19, the fetus infection rate is 33% through the placenta, the incidence of stillbirth 6.5%, the incidence of non immune fetal edema 8%~10%. Specific IgM and IgG antibodies are tested to diagnose whether pregnant women are infected with B19 virus. The appearance of IgG antibodies indicates previous infection, IgG antibodies remain positive all their lives and generally obtain lifelong immunity. If pregnant women have a certain level of anti-b19 virus specific IgG, it can protect the fetus, reduce the damage of B19 virus infection. Serological test to detect specific IgG and IgM antibodies is the basis for the diagnosis of B19 infection. Antibody detection methods mainly include radioimmunoassay (RIA) enzyme (ELISA) immunofluorescence assay (IF) and immunoblot assay (WB). This kit assists the detection of parvovirus B19 in pregnant women.
Contents of Kit
1. Microtiter Well 1 2. Negative Control 1 ml 3. Positive Control 1 ml 4. Sample Diluent 12 ml 5. Conjugate 12 ml 6. Washing Buffer (20×) 30 ml 7. Substrate Solution A 6 ml 8. Substrate Solution B 6 ml 9. Stop Solution 6 ml 10. Plate Cover 3 pieces 11. Insert 1 copy
Storage
Unopened test kits should be stored at 2-8°C. DO NOT FREEZE KIT COMPONNETS. The microtiter plate should be kept in a sealed bag to minimize exposure to damp air. Use up the reagents as soon as possible after the kit is unpacked.
Citations
Publication ()
Have you cited DEIA-JY24112 in a publication? Let us know and earn a reward for your research.
My Review for Human Parvovirus B19 IgG Antibody ELISA Kit
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.